• An overview of the current understanding of bleeding and thrombosis in cirrhosis.• An
evidence-based justification for bleeding risk assessment in patients with cirrhosis before …

This is the first clinical practice guideline (CPG) from the American Academy of Pediatrics
(AAP) regarding the management of infantile hemangiomas (IHs). Similar consensus …

Endothelial cells (ECs) are more than inert blood vessel lining material. Instead, they are
active players in the formation of new blood vessels (angiogenesis) both in health and (life …

Surgery is a mainstay treatment for patients with solid tumours. However, despite surgical
resection with a curative intent and numerous advances in the effectiveness of (neo) …

Summary With a prevalence of 4· 5%, infantile haemangiomas are the most common benign
tumours of infancy, arising in the first few weeks of life and exhibiting a characteristic …

Clinical decision making needs to be supported by evidence that treatments are beneficial to
individual patients. Although randomized control trials (RCTs) are the gold standard for …

Increased knowledge of the intricate pathogenesis of ulcerative colitis has triggered an
advance in drug development during the past two decades, resulting in the advent of several …

Abstract With a prevalence of 2.6–4.5%, infantile haemangiomas (IH) represent the most
common tumour of infancy. While the majority of IH does not require therapy and regresses …

Infantile hemangiomas (IHs) are the most common tumors of childhood. Unlike other tumors,
they have the unique ability to involute after proliferation, often leading primary care …

METHODS: We searched Embase and Medline databases (2007–July 2014) and
unpublished data from the manufacturer of Hemangiol/Hemangeol (marketed pediatric …